Low-cost video-assisted thoracic surgery lobectomy versus regular VATS lobectomy: a propensity-matched retrospective cohort study Authors: Taiyang Liuru, Dazhi Pang, Jitian Zhang, Guangqiang Shao, Jingsi Liu, Zhihai Liu, Ying Tang Published: 2025 ABSTRACT BackgroundThe study aims to compare the safety and cost-effectiveness of low-cost video-assisted thoracoscopic surgery (VATS) lobectomy, utilizing the twining high-tension knot method, with regular stapler-based VATS lobectomy.MethodsThis retrospective cohort study included 102 patients who underwent VATS lobectomy at a single center between January 2013 and April 2020. Patients were divided into a regular group (n = 57) and a low-cost group (n = 45). Propensity score matching (1:1) balanced baseline characteristics between the groups (45 patients each). Clinical and cost outcomes were analyzed.ResultsThe operative time (256.24 ± 87.45 min vs. 252.67 ± 73.46 min, p = 0.834), intraoperative blood loss (102.89 ± 96.38 mL vs.138.44 ± 257.07 mL, p = 0.39), and postoperative drainage tube indwelling time (3.04 ± 1.62 days vs. 4.02 ± 4.8 days, p = 0.19) were comparable between the low-cost and regular groups. The length of hospital stay was significantly lower in low-cost VATS (5.91 ± 2.51) compared to regular VATS (8.47 ± 7.39) (P = 0.03). The low-cost group demonstrated significantly reduced intraoperative consumable expenses (11,830.09 ± 7,565.13 CNY vs. 25,965.42 ± 7,441.93 CNY, P < 0.001) and total hospitalization costs (34,001.55 ± 12,649.06 CNY vs. 53,166.76 ± 10,966.48 CNY, P < 0.001).ConclusionsLow-cost VATS lobectomy, using the twining high-tension knot method, is as safe and effective as conventional stapler-based VATS lobectomy while significantly reducing costs. This innovative technique offers a practical, accessible alternative for minimally invasive thoracic surgery, particularly in resource-limited settings.Clinical trial registration number ChiCTR2100047430 in Chinese Clinical Trial Registry.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13019-025-03681-7. Introduction Video-assisted thoracoscopic surgery (VATS) lobectomy has gained widespread acceptance as a minimally invasive approach for managing pulmonary diseases such as lung cancer and bronchiectasis [1]. This technique offers superior clinical outcomes, including reduced pain, shorter hospital stays, and faster recovery times compared to traditional open thoracic surgery [2, 3]. However, these advantages come with a trade-off: the heavy reliance on disposable surgical consumables, such as endoscopic staplers, substantially increases procedure costs [4–6]. Endoscopic staplers are widely used in VATS lobectomy to seal and divide pulmonary vessels and bronchial structures. These devices simplify the surgical workflow and improve procedural safety but at a high financial cost [3]. Previous studies have highlighted the significant economic burden associated with these devices, reporting that the use of disposable staplers can account for up to half of the total intraoperative expenses in VATS lobectomy [7]. This issue is particularly pronounced in economically disadvantaged areas, where the affordability of minimally invasive surgery remains a significant barrier. Consequently, reducing the cost of surgical consumables without compromising patient safety has become a pressing priority in the field of thoracic surgery [8]. To address this challenge, we developed an innovative surgical technique called the “twining high-tension knot” method. This method eliminates the need for endoscopic staplers by using braided silk sutures to securely seal bronchial and vascular structures during VATS lobectomy. Unlike traditional open surgery techniques, which are technically challenging to replicate in a minimally invasive setting, the twining high-tension knot method has been specifically designed for thoracoscopic applications. It offers several practical advantages, including greater control over tissue tension, enhanced safety, and reduced risk of complications such as tissue tears or mechanical failure. Moreover, the technique is simple to learn, requires minimal additional training, and is compatible with standard thoracoscopic equipment, making it highly feasible for widespread adoption. The purpose of this study is to evaluate the clinical efficacy, safety, and cost-effectiveness of low-cost VATS lobectomy using the twining high-tension knot method compared to conventional stapler-based VATS lobectomy. We hypothesize that this low-cost approach will achieve comparable clinical outcomes while significantly reducing intraoperative and hospitalization expenses. By addressing the dual challenges of cost and accessibility, this study aims to provide an evidence-based alternative for expanding the availability of minimally invasive thoracic surgery, particularly in resource-limited settings. We presented this article in accordance with the STROBE reporting checklist. Methods Study design and setting This retrospective cohort study analyzed patients who underwent video-assisted thoracoscopic surgery (VATS) lobectomy at Hong Kong University-Shenzhen Hospital between January 2013 and April 2020. All procedures were performed by a single surgeon. The study aimed to compare the safety and cost-effectiveness of low-cost VATS lobectomy using the twining high-tension knot method with conventional VATS lobectomy utilizing endoscopic staplers. Ethical approval for the study was obtained from the institutional review board, and all patients provided written informed consent. The study is registered at the Chinese Clinical Trial Registry (Registration No. ChiCTR2100047430). Patient selection Patients eligible for inclusion in this study were adults aged 18 years and older who underwent video-assisted thoracoscopic surgery (VATS) lobectomy performed by the same experienced surgeon at our institution between January 2013 and April 2020. To ensure adequate respiratory reserve for lobectomy, patients were required to meet the following pulmonary function thresholds: (1) forced expiratory volume in 1 s (FEV1) > 1.5 L, (2) FEV1 > 80% of what would be expected for a healthy person of the same age, sex, height, and ethnicity (normal reference values), and (3) predicted postoperative FEV1 (PPO-FEV1) > 60% of expected values. Patients without comorbid respiratory diseases all had normal pulmonary function, while those with comorbidities still met the above criteria. We excluded patients who met any of the following criteria: those who underwent conversion to open lobectomy for non-complication-related reasons, patients who required resection of two or more pulmonary lobes, and those who had emergency or urgent VATS lobectomy procedures. Additionally, we excluded patients who were admitted to international medical care departments due to differing charging standards. Other exclusion factors included patients with active infections or those with a history of prior thoracic surgery, as these conditions could alter the surgical approach and outcomes. Furthermore, patients who were pregnant, had uncontrolled systemic diseases, or had contraindications to general anesthesia were also excluded from the study. Patient allocation and propensity score matching In this study, patients were not randomly allocated to the low-cost or regular VATS groups due to the retrospective nature of the study. Instead, patients were assigned to treatment arms based on the surgeon’s discretion and the patient’s preference at the time of surgery. To minimize selection bias, we performed propensity score matching (PSM) to balance key baseline characteristics between the two groups as described in the next sections. Surgical techniques In the regular VATS group, disposable endoscopic staplers were used to seal and divide pulmonary vessels and bronchial structures, with at least one stapler applied to these structures (Fig. 1A). Fig. 1(A) Endoscopic stapler device was used to seal and cut the bronchus, drawing by Dr. Liu JS (B) The bronchial tube is ligated with silk, drawing by Dr. Liu JS (A) Endoscopic stapler device was used to seal and cut the bronchus, drawing by Dr. Liu JS (B) The bronchial tube is ligated with silk, drawing by Dr. Liu JS In the low-cost VATS group, the twining high-tension knot method was employed for ligation of pulmonary arteries, veins, and bronchi with or without Hem-o-lok clips (Fig. 1B). Braided nonabsorbable silk sutures (2.5 metric or 3.5 metric for vessels and single or double 4 metric for bronchi) were used (Figure S1). The technique involved external knot tying followed by secure placement and tightening within the thoracic cavity using a knot pusher. Detailed procedural steps are shown in the Supplementary file (Figures S2-S4) and Additional File. For cases with incomplete fissure development, in both low-cost and conventional approaches, we used staplers for management. Staplers remain the most convenient, efficient, and safe method in this situation. It should be noted that the low-cost approach does not mean avoiding stapler use entirely, but rather minimizing its use. The number of cartridges used was dependent on fissure length and tissue thickness. Perioperative management Patients in both groups were managed according to the department’s thoracoscopic lobectomy clinical guideline. Postoperative care included admission to either the general or intensive care unit (ICU) based on clinical condition. Standard criteria for chest drainage removal included absence of air leak and less than 200 mL of total drainage volume within 24 h. The discharge criteria included normal vital signs, no complications requiring inpatient treatment, and no new pneumothorax or fluid pneumothorax after chest tube removal. Data collection and outcome measures Patient demographics, comorbidities, surgical details, and perioperative outcomes were retrospectively extracted from electronic medical records. Patient data included age, gender, baseline diseases, histological diagnosis, lobectomy location, selected surgical procedure, safety and clinical outcomes, and procedure-associated costs. For patients with malignant disease, additional oncologic parameters were recorded, including pathologic staging, tumor size, number of lymph node stations sampled, and total number of lymph nodes sampled. The primary outcomes of this study were clinical and cost indicators. Clinical outcomes included operative time (minutes), intraoperative blood loss (mL), postoperative drainage tube indwelling time (days), length of hospital stay (days), complication rates (severe and total complications, as the Common Terminology Criteria for Adverse Events version 5.0 [9]), and the need for conversion to open surgery or intraoperative blood transfusion. Cost-related outcomes included the number and expense of disposable endoscopic staplers, intraoperative single-use consumable expenses, and total hospitalization costs. Follow-up was conducted up to 10 months after the operation regarding mortality and need for reoperation. Statistical analysis and propensity score matching The PSM was performed to minimize potential selection bias inherent in our retrospective cohort design. Specifically, we selected baseline demographic and clinical variables that could plausibly influence both the choice of surgical technique and postoperative outcomes. These included age, gender, underlying lung disease, and systemic diseases (cardiovascular disease, diabetes, and others). We constructed a logistic regression model with the surgical technique (low-cost VATS vs. regular VATS) as the dependent variable and the above baseline variables as independent covariates. 1:1 nearest-neighbor matching without replacement was performed using the logit of the propensity score. We used a caliper width of 0.2 of the standard deviation of the logit of the propensity score, as recommended by Austin (2011) [10]. All analysis was performed using R version 4.4.3. Covariate balance was assessed by comparing standardized mean differences (SMDs) before and after matching. The matching variables included age, gender, underlying lung disease, and systemic diseases. We utilized 1:1 nearest-neighbor matching with a caliper width of 0.2 to ensure close matching between the groups. Continuous variables were presented as mean ± standard deviation (SD) or median [interquartile range (IQR)], depending on the distribution’s normality. Categorical variables were reported as frequencies and percentages. Statistical analyses were performed using the Student’s t-test or Mann-Whitney U-test for continuous variables and Pearson’s χ² test or Fisher’s exact test for categorical variables. In addition to the primary analysis, we performed a subgroup analysis considering the presence or absence of pulmonary comorbidities. The goal was to further evaluate the impact of the low-cost VATS lobectomy method, excluding potential confounding by respiratory conditions. All statistical analysis was performed using SPSS (IBM Corp, Armonk, NY, USA). A two-sided p-value of < 0.05 was considered statistically significant. Results Patient characteristics A total of 102 patients who underwent video-assisted thoracoscopic surgery (VATS) lobectomy between January 2013 and April 2020 were included in this study. Among them, 64 patients underwent regular VATS lobectomy, while 46 patients underwent low-cost VATS lobectomy. One patient in the low-cost group was excluded due to the resection of two lobes. In the regular group, 4 patients were excluded due to resection of two lobes, 2 patients were excluded due to intraoperative adhesion and conversion to open lobectomy, and 1 patient was excluded due to emergency VATS lobectomy. After propensity score matching (PSM), both groups consisted of 45 patients with well-balanced baseline characteristics (Fig. 2). Fig. 2Flowchart of patient selection process. VATS, video-assisted thoracic surgery Flowchart of patient selection process. VATS, video-assisted thoracic surgery The standardized mean differences (SMD) for key covariates before and after matching, as shown in Fig. 3, confirm that the groups were well-balanced after matching. After PSM, all baseline variables had SMDs < 0.2 and no statistically significant differences between groups (as shown in Table 1). Fig. 3Covariate balance before and after propensity score matching (PSM). The Love plot shows the absolute standardized mean differences for age, gender, underlying lung disease, and systemic diseases. Red dots represent the values before PSM, and blue dots represent the values after PSM, demonstrating improved balance post-matching Covariate balance before and after propensity score matching (PSM). The Love plot shows the absolute standardized mean differences for age, gender, underlying lung disease, and systemic diseases. Red dots represent the values before PSM, and blue dots represent the values after PSM, demonstrating improved balance post-matching Table 1– Baseline demographic and clinical characteristics of two VATS groupsVariableLow-cost VATS(n = 45)Regular VATS(n = 45)p-valueAge58.40 ± 12.6460.51 ± 13.900.45GenderMale13 (28.9)14 (31.1)1.00Female32 (71.1)31 (68.9)Underlying lung diseaseYes3 (6.7)10 (22.2)0.07No42 (93.3)35 (77.8)Cardio-cerebrovascular diseaseYes14 (31.1)10 (22.2)0.48No31 (68.9)35 (77.8)DiabetesYes2 (4.4)6 (13.3)0.27No43 (95.6)39 (86.7)Other systemic diseasesYes2 (4.4)4 (8.9)0.67No43 (95.6)40 (91.1)Histological diagnosisAdenocarcinoma34 (75.6)37 (82.2)0.43SCC4 (8.9)6 (13.3)Bronchiectasis3 (6.7)1 (2.2)TB or other infections2 (4.4)1 (2.2)Other2 (4.4)0 (0.0)Location of lung resectionRUL11 (24.4)17 (37.8)0.33RML8 (17.8)3 (6.7)RLL8 (17.8)11 (24.4)LUL7 (15.6)6 (13.3)LLL11 (24.4)8 (17.8)Underwent wedge resection before lobectomyYes9 (20.0)18 (40.0)0.07No36 (80.0)27 (60.0)Discrete data are expressed as count with percentages: n (%); continuous data are expressed as mean ± SD. VATS, video-assisted thoracoscopic surgery; TB, Tuberculosis; PSM, propensity score matching; SCC, Squamous cell carcinomas; RUL, Right upper lobe; RML, Right middle lobe; RLL, Right lower lobe; LUL, Left upper lobe; LLL, Left lower lobe Table 1– Baseline demographic and clinical characteristics of two VATS groupsVariableLow-cost VATS(n = 45)Regular VATS(n = 45)p-valueAge58.40 ± 12.6460.51 ± 13.900.45GenderMale13 (28.9)14 (31.1)1.00Female32 (71.1)31 (68.9)Underlying lung diseaseYes3 (6.7)10 (22.2)0.07No42 (93.3)35 (77.8)Cardio-cerebrovascular diseaseYes14 (31.1)10 (22.2)0.48No31 (68.9)35 (77.8)DiabetesYes2 (4.4)6 (13.3)0.27No43 (95.6)39 (86.7)Other systemic diseasesYes2 (4.4)4 (8.9)0.67No43 (95.6)40 (91.1)Histological diagnosisAdenocarcinoma34 (75.6)37 (82.2)0.43SCC4 (8.9)6 (13.3)Bronchiectasis3 (6.7)1 (2.2)TB or other infections2 (4.4)1 (2.2)Other2 (4.4)0 (0.0)Location of lung resectionRUL11 (24.4)17 (37.8)0.33RML8 (17.8)3 (6.7)RLL8 (17.8)11 (24.4)LUL7 (15.6)6 (13.3)LLL11 (24.4)8 (17.8)Underwent wedge resection before lobectomyYes9 (20.0)18 (40.0)0.07No36 (80.0)27 (60.0)Discrete data are expressed as count with percentages: n (%); continuous data are expressed as mean ± SD. VATS, video-assisted thoracoscopic surgery; TB, Tuberculosis; PSM, propensity score matching; SCC, Squamous cell carcinomas; RUL, Right upper lobe; RML, Right middle lobe; RLL, Right lower lobe; LUL, Left upper lobe; LLL, Left lower lobe – Baseline demographic and clinical characteristics of two VATS groups Discrete data are expressed as count with percentages: n (%); continuous data are expressed as mean ± SD. VATS, video-assisted thoracoscopic surgery; TB, Tuberculosis; PSM, propensity score matching; SCC, Squamous cell carcinomas; RUL, Right upper lobe; RML, Right middle lobe; RLL, Right lower lobe; LUL, Left upper lobe; LLL, Left lower lobe We also showed the distribution of the PSM score in matched and unmatched groups in the supplementary file. (Figure S5). In the final analysis, there were no significant differences between the two groups in terms of age, gender, underlying lung disease, cardio-cerebrovascular disease, diabetes, other systemic diseases, histological diagnosis, location of lung resection, and undergoing wedge resection before lobectomy after PSM (Table 1). Among patients with malignant disease, there were no significant differences in terms of pathologic staging, tumor size, number of lymph node stations sampled, and total number of lymph nodes sampled between the two groups (Table S1). Operative results and clinical outcomes The operative outcomes demonstrated no significant differences between the low-cost and regular VATS groups. There were no perioperative deaths or deaths within the follow-up period in either group. The mean operative time was 256.24 ± 87.45 min in the low-cost group compared to 252.67 ± 73.46 min in the regular group (p = 0.83). Intraoperative blood loss was slightly lower in the low-cost group (102.89 ± 96.38 mL) than in the regular group (138.44 ± 257.07 mL), but this difference was not statistically significant (p = 0.39). Postoperative drainage tube indwelling time was also comparable between the groups (3.04 ± 1.62 days in low-cost VATS vs. 4.02 ± 4.8 days in regular VATS, p = 0.19). The length of hospital stay was significantly lower in low-cost VATS (5.91 ± 2.51) compared to regular VATS (8.47 ± 7.39) (P = 0.03) (Fig. 4). Fig. 4The Comparison between the clinical outcomes of low-cost and regular VATS The Comparison between the clinical outcomes of low-cost and regular VATS None of the patients in the low-cost group required blood transfusion or conversion to regular VATS or open surgery due to complications. Only one of the patients in the regular VATS group needed a blood transfusion and was converted to open in the regular group because of pulmonary artery injury and hemorrhage during the operation. The overall complication rates were 15.56% (n = 7) in the low-cost group and 22.22% (n = 10) in the regular group, with no statistically significant difference (P = 0.42). Specific complications included air leakage, pulmonary infection, poor incision healing, and chylothorax, with similar distribution between the groups. No severe complications occurred in the low-cost group, meanwhile, two cases of severe complications occurred in the regular group (4.44%) (P = 0.49) (Table 2), including one case of bronchopleural fistula requiring emergency reoperation the day after surgery. During operation, it was found that a small bronchial branch variation may cause air leakage when coughing, and no air leak was found in the bronchial stump. The other case was an intraoperative pulmonary artery rupture due to extensive tension on the artery when using staplers requiring conversion to open surgery. Four units of red cell suspension (RCS) were used. Both patients with severe complications recovered and were successfully discharged. Table 2Comparison of perioperative and cost outcomes between two VATS groupsOutcomeLow-cost group (n = 45)Regular group (n = 45)p-valueOperation time (min)256.24 ± 87.45252.67 ± 73.460.83 aIntraoperative blood loss (mL)102.89 ± 96.38138.44 ± 257.070.39 aPostoperative drainage tube indwelling time (days)3.04 ± 1.624.02 ± 4.80.19 aPostoperative length of stay (days)5.91 ± 2.518.47 ± 7.390.03 aNeed for blood transfusion0 (0)1 (2.22%)1 bConverting to thoracotomy0 (0)1 (2.22%)1 bComplication rate7 (15.56%)10 (22.22%)0.42 c- Air leakage4 (8.88%)3 (6.66%)- Atelectasis02 (4.44%)- Infection1 (2.22%)1 (2.22%)- Chylothorax1 (2.22%)1 (2.22%)- Poor incision healing1 (2.22%)0- Bronchopleural fistula01 (2.22%)- Arterial bleeding01 (2.22%)- Pleural effusion01 (2.22%)Severe complication rate0 (0.00%)2 (4.44%)0.49 bStapler handles0 (1)1 (0)< 0.001 dStapler nails0 (4)6 (5)< 0.001 dStapler nails (Without wedge resection)0 (2)5 (2)< 0.001 dTotal hospital expenses(CNY)36612.68 ± 13915.2257058.37 ± 12804.10< 0.001 a(USD)5594.42 ± 2126.258718.52 ± 1956.47Total hospital expenses (Without wedge resection)(CNY)34001.55 ± 12649.0653166.76 ± 10966.48< 0.001 a(USD)5195.44 ± 1932.788123.88 ± 1675.68Intraoperative single-use consumable expenses(CNY)14441.21 ± 10554.3229857.02 ± 9908.39< 0.001 a(USD)2206.62 ± 1612.704562.15 ± 1514.00Intraoperative single-use consumable expenses(Without wedge resection)(CNY)11830.09 ± 7565.1325965.42 ± 7441.93< 0.001 a(USD)1807.64 ± 1155.953967.52 ± 1137.13Discrete data are expressed as count with percentages: n (%); continuous data are expressed as mean ± SD or median (25%−75% percentiles). PSM, propensity score matching; CNY, Chinese Yuan, USD, United States DollarBold values denote statistically significant differences (p < 0.05).a Independent-T testb Fisher-exact testc Chi-square testd Mann-Whitney test Table 2Comparison of perioperative and cost outcomes between two VATS groupsOutcomeLow-cost group (n = 45)Regular group (n = 45)p-valueOperation time (min)256.24 ± 87.45252.67 ± 73.460.83 aIntraoperative blood loss (mL)102.89 ± 96.38138.44 ± 257.070.39 aPostoperative drainage tube indwelling time (days)3.04 ± 1.624.02 ± 4.80.19 aPostoperative length of stay (days)5.91 ± 2.518.47 ± 7.390.03 aNeed for blood transfusion0 (0)1 (2.22%)1 bConverting to thoracotomy0 (0)1 (2.22%)1 bComplication rate7 (15.56%)10 (22.22%)0.42 c- Air leakage4 (8.88%)3 (6.66%)- Atelectasis02 (4.44%)- Infection1 (2.22%)1 (2.22%)- Chylothorax1 (2.22%)1 (2.22%)- Poor incision healing1 (2.22%)0- Bronchopleural fistula01 (2.22%)- Arterial bleeding01 (2.22%)- Pleural effusion01 (2.22%)Severe complication rate0 (0.00%)2 (4.44%)0.49 bStapler handles0 (1)1 (0)< 0.001 dStapler nails0 (4)6 (5)< 0.001 dStapler nails (Without wedge resection)0 (2)5 (2)< 0.001 dTotal hospital expenses(CNY)36612.68 ± 13915.2257058.37 ± 12804.10< 0.001 a(USD)5594.42 ± 2126.258718.52 ± 1956.47Total hospital expenses (Without wedge resection)(CNY)34001.55 ± 12649.0653166.76 ± 10966.48< 0.001 a(USD)5195.44 ± 1932.788123.88 ± 1675.68Intraoperative single-use consumable expenses(CNY)14441.21 ± 10554.3229857.02 ± 9908.39< 0.001 a(USD)2206.62 ± 1612.704562.15 ± 1514.00Intraoperative single-use consumable expenses(Without wedge resection)(CNY)11830.09 ± 7565.1325965.42 ± 7441.93< 0.001 a(USD)1807.64 ± 1155.953967.52 ± 1137.13Discrete data are expressed as count with percentages: n (%); continuous data are expressed as mean ± SD or median (25%−75% percentiles). PSM, propensity score matching; CNY, Chinese Yuan, USD, United States DollarBold values denote statistically significant differences (p < 0.05).a Independent-T testb Fisher-exact testc Chi-square testd Mann-Whitney test Comparison of perioperative and cost outcomes between two VATS groups Intraoperative single-use consumable expenses (Without wedge resection) Discrete data are expressed as count with percentages: n (%); continuous data are expressed as mean ± SD or median (25%−75% percentiles). PSM, propensity score matching; CNY, Chinese Yuan, USD, United States Dollar Bold values denote statistically significant differences (p < 0.05). a Independent-T test b Fisher-exact test c Chi-square test d Mann-Whitney test Subgroup analysis considering the underlying lung disease in each group revealed no significant differences among none of the above parameters between patients who had underlying lung disease and those who did not have (Table S2). Cost analysis The low-cost VATS lobectomy group demonstrated significantly reduced intraoperative consumables and hospitalization costs compared to the regular VATS group. In the low-cost group, the number of Endo-GIA stapler handles used (Median [IQR] 0 [0–1] vs. 1 [1–1], P < 0.001), the number of Endo-GIA stapler nails used (Median [IQR] 0 [0–4] vs. 6 [4–9], P < 0.001) were significantly less than those in the regular group. The difference remains significant even after subtracting the ones used during preoperative wedge resection (Median [IQR] 0 [0–2] vs. 5 [4–6], P < 0.001) (Table 2). The mean intraoperative single-use consumable expenses were 14,441.21 ± 10,554.32 CNY in the low-cost group versus 29,857.02 ± 9,908.39 CNY in the regular group (P < 0.001). Similarly, the total hospitalization cost was significantly lower in the low-cost group (36,612.68 ± 13,915.22 CNY) compared to the regular group (57,058.37 ± 12,804.10 CNY, P < 0.001) (Table 2). Even after excluding the cost of endoscopic staplers used during possible preoperative wedge resection, the low-cost group incurred lower expenses for both intraoperative consumables (11,830.09 ± 7,565.13 CNY vs. 25,965.42 ± 7,441.93 CNY, P < 0.001) and total hospitalization (34,001.55 ± 12,649.06 CNY vs. 53,166.76 ± 10,966.48 CNY, P < 0.001). In other words, the intraoperative one-time consumable expenses and the total hospital expenses in the low-cost group were only 46% and 64% of those in the regular group. The proportion of intraoperative consumable expenses relative to total hospital costs was reduced by 14% in the low-cost group, accounting for 35% of total expenses compared to 49% in the regular group (Table 2). Discussion This study demonstrates that low-cost VATS lobectomy, employing the twining high-tension knot method, is a safe and cost-effective alternative to the conventional stapler-based VATS lobectomy. Our findings indicate that the low-cost technique achieves comparable clinical outcomes in terms of operation time, blood loss, postoperative recovery, and complication rates while significantly reducing intraoperative consumable expenses and total hospitalization costs. These results have important implications for expanding access to minimally invasive thoracic surgery, particularly in resource-limited settings. The safety of low-cost VATS lobectomy was evidenced by similar operative and postoperative outcomes compared to the regular VATS group. Operation times, intraoperative blood loss, and postoperative drainage durations were not significantly different between the groups, suggesting that the adoption of the twining high-tension knot technique does not increase surgical complexity or recovery times. Furthermore, the complication rates, including both minor and severe events, were comparable, with no severe complications observed in the low-cost group. These findings align with prior studies that have highlighted the technical feasibility of suture-based approaches in thoracic surgery as viable alternatives to stapler-dependent techniques [11, 12]​​. While the immediate postoperative complications observed in this study were consistent with those commonly seen in VATS lobectomy, it is important to consider that some adverse events may emerge in the long term. The use of sutures in place of staplers offers significant cost savings, but it may also present unique risks related to suture integrity, such as the possibility of vascular or bronchial leakage over time. Additionally, sutures may be prone to foreign body reactions or chronic inflammatory responses, which could affect the patient’s long-term recovery. Although we observed no severe complications related to suture failure during the follow-up period, the 10-month follow-up in this study may not be sufficient to capture delayed complications. Moreover, the impact of suture-related stenosis or delayed tissue healing requires further investigation, particularly in patients with complex pulmonary comorbidities. Future studies with longer follow-up are necessary to evaluate these potential long-term risks more thoroughly. The conventional approach to knot tying in VATS has two drawbacks. Securing a tight knot is difficult under conditions of high tissue tension. The knot must be advanced with force by the knot pusher during the knot-tying process. Inadvertent injury to surrounding tissues may occur if the knot pusher slips [13–15]. Considering these drawbacks, we have developed a novel method of VATS knotting that presents significant advantages. Significantly, increased force can be exerted at the online knot to enhance its tightness and firmness. The method of applying force is based on the finger’s action to drive the cable, rather than depending on the forward push of the knot pusher. This approach eliminates the risk of slippage of the knot pusher and the potential for accidental injury. This novel knot-tying method is safer, more reliable, and simpler to operate than traditional methods, with a low learning cost, making it suitable for clinical practice. One of the most notable findings of this study is the substantial reduction in costs associated with the low-cost technique. The intraoperative single-use consumable expenses and total hospitalization costs in the low-cost group were approximately 46% and 64% lower, respectively, than those in the regular group. This cost-effectiveness can be attributed to the elimination of expensive endoscopic staplers, which accounted for nearly half of the intraoperative expenses in the regular group [7]. These results are consistent with studies from other healthcare systems, which have emphasized the disproportionate financial burden of disposable surgical consumables on the overall cost of minimally invasive procedures​ [16–18]. The significant cost savings observed in this study highlight the potential of the twining high-tension knot method to make VATS lobectomy more accessible to patients in economically disadvantaged regions. The twining high-tension knot method offers several practical advantages. Compared to endoscopic staplers, the use of braided silk sutures provides greater flexibility, reduced tissue tension, and decreased the risk of mechanical failure, such as incomplete staple formation. Additionally, this method is less likely to cause tissue tears, particularly in cases of friable pulmonary vessels or bronchial anomalies. The technical simplicity and low learning curve of the knotting method further enhance its feasibility for widespread adoption. These benefits, combined with the substantial cost reduction, suggest that this technique could address critical barriers to minimally invasive thoracic surgery, particularly in healthcare systems with limited financial resources [19]. Despite its promising findings, this study has several limitations. First, as a retrospective cohort study, it is subject to inherent biases, including the potential for unmeasured confounding variables despite the use of PSM. Selection bias cannot be entirely excluded, as patients were not randomly assigned to the low-cost or regular VATS groups, and allocation was based on surgeon discretion and patient preference. Although PSM helped reduce bias in the observed clinical characteristics, there may still be variables not captured by the matching process that could influence postoperative outcomes. Second, the study was conducted at a single center with procedures performed by a single surgeon. While this approach ensures consistency in technique and reduces variability, it may limit the generalizability of the results. The experience and skill level of the surgeon performing the procedures could have influenced the outcomes, particularly early in the study, as the low-cost VATS technique was adopted. Moreover, the relatively modest sample size of 100 lobectomies performed over a 7-year period in this study raises pertinent questions regarding the potential impact of the learning curve on surgical outcomes. The learning curve in VATS lobectomy refers to the time and experience required for a surgeon to achieve proficiency in performing the procedure with consistent safety and efficacy. Studies have shown that the learning curve for VATS lobectomy can vary, with some suggesting that approximately 50 procedures may be needed to attain technical competence. Additionally, factors such as the number of procedures and the presence of experienced mentors can influence the duration of the learning curve [20, 21]. As noted above, all procedures in our study were conducted by a single surgeon, which may have mitigated some of the variability associated with the learning curve. It is important to note that while the surgeon’s experience in VATS lobectomy may have influenced the results, the relatively low number of cases performed over the study period suggests that the learning curve could have had an impact on the outcomes observed. Future studies with larger sample sizes and a broader range of surgeons at different levels of experience are needed to assess the reproducibility and safety of the low-cost VATS technique across various clinical settings. Moreover, the median operative time in both groups may appear longer than reported in some previous studies [22–24]. This might reflect our study’s complex cases, and learning curve impact as noted above. As the study spans 2013–2020, initial cases required more time due to the learning curve for the twining high-tension knot method. Additionally, our institution is a teaching hospital, and trainees often participate in surgical steps under supervision, which can extend operative duration. It is important to note that, in the final two years of the study, operative times were comparable to published averages for VATS lobectomies [22–24]. Future studies conducted at multiple centers with different surgeons will be essential to validate the findings and determine whether these results can be replicated across varied practice settings. Third, the follow-up period was limited to 10 months, which precludes long-term evaluation of surgical outcomes and potential complications. Furthermore, our study’s sample size of 45 patients per group may limit the statistical power to detect differences in less frequent outcomes such as complications and reoperation rates. While the observed trends suggest that the low-cost VATS lobectomy technique is comparable to the regular technique in terms of these outcomes, the small sample size warrants caution in interpreting the results. However, it should be noted that this sample size is adequate for a pilot study to ensure the validity and cost-effectiveness of a new technique to further explore its long-term safety and efficacy in a larger trial setting. Larger multicenter prospective randomized controlled trials with higher statistical power would be valuable to further evaluate the impact of the low-cost technique on rare but clinically significant outcomes. Extended follow-up is also necessary to evaluate long-term outcomes, including survival and recurrence rates for malignant conditions. Furthermore, studies examining the cost-effectiveness of the twining high-tension knot method in different healthcare settings would provide valuable insights for policymakers. Considering all these limitations, we are going to perform a multi-center randomized clinical trial to assess the results. Conclusion In conclusion, this study provides strong evidence that low-cost VATS lobectomy using the twining high-tension knot method is a safe and economically viable alternative to conventional stapler-based VATS lobectomy. By significantly reducing surgical costs without compromising safety or efficacy, this technique has the potential to expand access to minimally invasive thoracic surgery, particularly in underserved populations. Future studies should explore the long-term outcomes and broader implementation of this technique across diverse healthcare systems. Supplementary Information Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3 Supplementary Material 4 Supplementary Material 4 Supplementary Material 5 Supplementary Material 5 Supplementary Material 6 Supplementary Material 6 Supplementary Material 7 Supplementary Material 7 Supplementary Material 8 Supplementary Material 8 Supplementary Material 9 Supplementary Material 9